EP2569010
Mótefnasamsetningar í háum styrk
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.5.2011EP published:
12.4.2017EP application number:
11720278.8
EP translation filed:
28.4.2017Grant published:
15.5.2017EPO information:
European Patent Register
Max expiry date:
10.5.2031Expiry date:
10.5.2026Next due date:
31.5.2026
Title:
HIGH CONCENTRATION ANTIBODY FORMULATIONS
Timeline
Today
11.5.2011EP application
12.4.2017EP Publication
28.4.2017Translation submitted
15.5.2017Registration published
10.5.2026Expires
Owner
Name:
Amgen, IncAddress:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
OSSLUND, Timothy, D.Address:
Camarillo, CA, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
334986 PDate:
14.5.2010Country:
US
Classification
Categories:
A61K 39/395, A61K 47/12, C07K 16/22
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.5.2017
Expires: 10.5.2018
Payer: Árnason Faktor
Number: 8
Paid: 9.4.2018
Expires: 10.5.2019
Payer: Árnason Faktor
Number: 9
Paid: 5.4.2019
Expires: 10.5.2020
Payer: Árnason Faktor
Number: 10
Paid: 27.4.2020
Expires: 10.5.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.4.2021
Expires: 10.5.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.4.2022
Expires: 10.5.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 28.4.2023
Expires: 10.5.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.4.2024
Expires: 10.5.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 29.4.2025
Expires: 10.5.2026
Payer: Árnason Faktor ehf.